Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Formulation approaches to improving the delivery of an antiviral drug with activity against seasonal flu.

Sammeta SM, Wang L, Mutyam SK, O'Loughlin K, Green CE, Werner MH, Kelly T, Shankar GN.

Pharm Dev Technol. 2015 Mar;20(2):169-75. doi: 10.3109/10837450.2013.852574.

PMID:
24218989
2.

The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems.

Sun M, Si L, Zhai X, Fan Z, Ma Y, Zhang R, Yang X.

Drug Dev Ind Pharm. 2011 Aug;37(8):986-94. doi: 10.3109/03639045.2011.553618.

PMID:
21417621
3.

Permeability enhancing lipid-based co-solvent and SEDDS formulations of SQ641, an antimycobacterial agent.

Mutyam SK, Bejugam NK, Parish HJ, Reddy VM, Bogatcheva E, Shankar GN.

Pharm Dev Technol. 2015;20(5):598-607. doi: 10.3109/10837450.2014.908304.

PMID:
24946795
4.

Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.

Nair AB, Attimarad M, Al-Dhubiab BE, Wadhwa J, Harsha S, Ahmed M.

Drug Deliv. 2014 Nov;21(7):540-7. doi: 10.3109/10717544.2013.853213.

PMID:
24215288
5.

Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin.

Mekjaruskul C, Yang YT, Leed MG, Sadgrove MP, Jay M, Sripanidkulchai B.

Int J Pharm. 2013 Mar 10;445(1-2):1-11. doi: 10.1016/j.ijpharm.2013.01.052.

PMID:
23376503
6.

Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.

Madan J, Dhiman N, Parmar VK, Sardana S, Bharatam PV, Aneja R, Chandra R, Katyal A.

Cancer Chemother Pharmacol. 2010 Feb;65(3):537-48. doi: 10.1007/s00280-009-1060-3.

PMID:
19597818
7.

Solubilizing excipients in oral and injectable formulations.

Strickley RG.

Pharm Res. 2004 Feb;21(2):201-30. Review.

PMID:
15032302
8.

Improvement of pulmonary absorption of cyclopeptide FK224 in rats by co-formulating with beta-cyclodextrin.

Nakate T, Yoshida H, Ohike A, Tokunaga Y, Ibuki R, Kawashima Y.

Eur J Pharm Biopharm. 2003 Mar;55(2):147-54.

PMID:
12637090
9.

Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.

Fei Y, Kostewicz ES, Sheu MT, Dressman JB.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1274-84. doi: 10.1016/j.ejpb.2013.03.001.

PMID:
23500116
11.

Preparation and evaluation of bicyclol microemulsions for enhanced oral bioavailability.

Ryu JK, Yoo SD.

Drug Dev Ind Pharm. 2012 Nov;38(11):1313-8.

PMID:
22283588
15.

Cyclodextrins in drug delivery.

Loftsson T, Jarho P, Másson M, Järvinen T.

Expert Opin Drug Deliv. 2005 Mar;2(2):335-51. Review.

PMID:
16296758
16.
17.

Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.

Wu J, Shen Q, Fang L.

Drug Dev Ind Pharm. 2013 Jul;39(7):1010-9. doi: 10.3109/03639045.2012.694588.

PMID:
22681515
18.

Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).

Rahman MA, Hussain A, Hussain MS, Mirza MA, Iqbal Z.

Drug Dev Ind Pharm. 2013 Jan;39(1):1-19. doi: 10.3109/03639045.2012.660949. Review.

PMID:
22372916
19.

Optimized formulation of solid self-microemulsifying sirolimus delivery systems.

Cho W, Kim MS, Kim JS, Park J, Park HJ, Cha KH, Park JS, Hwang SJ.

Int J Nanomedicine. 2013;8:1673-82. doi: 10.2147/IJN.S43299.

20.

Preparation and characterization of microemulsion of cilostazol for enhancement of oral bioavailability.

Patel SG, Rajput SJ, Groshev A, Sutariya VB.

Curr Drug Deliv. 2014;11(4):531-40.

PMID:
24274587
Items per page

Supplemental Content

Support Center